Literature DB >> 949176

Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.

H C Neu.   

Abstract

The in vitro activity of mecillinam, a 6 beta-amidinopenicillanic acid derivative, was investigated. Mecillinam is not active against most gram-positive coccal or bacilliary forms. Many members of the Enterobacteriaceae are inhibited, with 86% of Escherichia coli, 71% of Klebsiella, 62% of Enterobacter, 75% of Salmonella, 69% of Shigella, and 70% of Citrobacter inhibited by 6.3 mug/ml. Indole-positive Proteus and Serratia were generally resistant as are Pseudomonas strains. Although mecillinam is hydrolyzed by gram-negative beta-lactamases, the compound inhibits beta-lactamase-producing organisms, particularly E. coli. The conductivity of medium used to determine minimal inhibitory concentration and inoculum size produce markedly different values. In medium of high conductivity, 10 mS, mecillinam is inactive against many strains of bacteria. In all media there is a great difference between the minimal inhibitory and minimal bactericidal levels.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 949176      PMCID: PMC429623          DOI: 10.1128/AAC.9.5.793

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: in vitro evaluation.

Authors:  L Tybring
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1972-10

3.  FL-1060: a new penicillin with a unique mode of action.

Authors:  J T Park; L Burman
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

4.  Light and electron microscopy of the early response of Escherichia coli to a 6beta-amidinopenicillanic acid (FL 1060).

Authors:  N H Melchior; J Blom; L Tybring; A Birch-Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-08

5.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

6.  Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin.

Authors:  M Finland; J E McGowan; C Garner; C Wilcox
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

7.  Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

8.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

9.  FL 1060: a new beta-lactam antibiotic with novel properties.

Authors:  D Greenwood; F O'Grady
Journal:  J Clin Pathol       Date:  1973-01       Impact factor: 3.411

10.  Mechanism of action and development of resistance to a new amidino penicillin.

Authors:  S Matsuhashi; T Kamiryo; P M Blumberg; P Linnett; E Willoughby; J L Strominger
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

View more
  28 in total

1.  Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.

Authors:  A Ohno; Y Ishii; L Ma; K Yamaguchi
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Growth properties of mecillinam-resistant bacterial variants in urine.

Authors:  J D Anderson; M A Adams; H M Webster; L Smith
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

3.  High and selective resistance to mecillinam in adenylate cyclase-deficient or cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli.

Authors:  R Aono; M Yamasaki; G Tamura
Journal:  J Bacteriol       Date:  1979-02       Impact factor: 3.490

4.  Critical evaluation of amdinocillin disk susceptibility tests correlated with agar dilution tests.

Authors:  A L Barry
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

5.  Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.

Authors:  J Klastersky; L Coppens; F Meunier-Carpentier; A P Menday
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

Review 6.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Comparison of the effects of mecillinam and 6-aminopenicillanic acid on Proteus mirabilis, Escherichia coli, and Staphylococcus aureus.

Authors:  V Lorian; B Atkinson
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

8.  Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Infection       Date:  1982       Impact factor: 3.553

9.  Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.

Authors:  J Berenguer; M A de Pedro; D Vázquez
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

10.  Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.

Authors:  U B Schaad; L M Grimm; G Beskid; R Cleeland; J D Nelson; G H McCracken
Journal:  Infection       Date:  1982       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.